Pinetree Therapeutics
PrivateLast Round
Series B
Oct 28, 2025
Est. Valuation
$135M
Total Funding Raised
$87.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Pinetree Therapeutics is a biotechnology company developing transformative therapies through targeted protein degradation for oncology and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pinetree Therapeutics Comparables
Compare Pinetree Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EpiBiologics | 85% | |
| Lycia Therapeutics | 84% | |
| Avilar Therapeutics | 79% | |
Pinetree Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 28, 2025 | ||||
| Series A Extension | Jul 30, 2024 | ||||
| Series A | Jun 7, 2022 |
Pinetree Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| InterVest | Series A |
| SV Investment | Series B |
| DSC Investment | Series B, Series A, Series A Extension |
| Smilegate Investment | Series B |
| STIC Investments | Series A Extension |
| Korea Investment Partners | Series B |
| S&S Investment | Series B, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 65% MoM, reaching 2.9K.
- Jun 17, 2026
Monthly visitors increased 49% MoM.
Pinetree Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pinetree Therapeutics's valuation, stock price, and market status.